Christopher Cychosz, MD
Foot and Ankle Surgery · Eugene, ORNPI 1801322953
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Paragon 28, Inc. at 31.3% of the total. Reporting peaked in 2022 at $4,072 and has fallen 95.8% since, to $171 in 2025.
Across 63 payments — averaging $121.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$2K
- Arthrex$2K
- Exactech, Inc.$964
- Medical Device Business Services, Inc.$690
- Stryker$646
- Suvon Surgical LLC$603
- plus $749 from 7 others
What the payments were for
- Travel & lodging$4,29556%
- Food & beverage$2,72836%
- Education$6498%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 9 | $2,403 |
| Arthrex | 17 | $1,617 |
| Exactech, Inc. | 4 | $964 |
| Medical Device Business Services, Inc. | 6 | $690 |
| Stryker | 8 | $646 |
| Suvon Surgical LLC | 3 | $603 |
| Steelhead Surgical Inc | 5 | $298 |
| Zimmer Biomet | 2 | $258 |
| Medtronic(2 entities) | 4 | $59 |
| Sanara Medtech Inc. | 1 | $58 |
| Johnson & Johnson | 2 | $37 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Sonex Health, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Product Portfolio$2,304
- VANTAGE$937
- INBONE$278
- AUGMENT INJECTABLE$155
- mymobility Platform$148
- ROSA$148
How this compares
$7,672 in reported general payments places this provider in the 75th percentile of 113 foot and ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 71 | $374 |
| Cephalexin | 32 | $262 |
| Ondansetron OdtOndansetron | 28 | $175 |
| Doxycycline Monohydrate | 12 | $149 |
| Gabapentin | 17 | $143 |
| Ondansetron Hcl | 19 | $122 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $82 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $73 |
| Tramadol Hcl | 21 | $40 |
| Meloxicam | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Eugene
- Lyle JacksonEugene$8K
- Philip McKinneyEugene$4K
- Thomas YatesEugene$4K
- Drew PearsonEugene$3K
- Jacob GreenEugene$3K
- Natalie MesnierPortland$339K
- Stephen WallaceLake Oswego$205K
- Scott BoyntonPortland$120K
- Andrew ShinabargerPortland$85K
- Cassandra TomczakTualatin$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.